BTAIVSGTBP• 6 Months (Normalized)
BTAI vs GTBP (BioXcel Therapeutics Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Mar 29 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
-97.08%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-97.08 pts
GTBP outperforming by 97.08 percentage points
BTAIGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | BTAI Price | BTAI Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $0.04 | -97.08% | $- | - | |
| Sep 23, 2026 | $0.05 | -96.28% | $7.10 | +1614.98% | -1711.26% |
| Sep 22, 2026 | $0.04 | -96.31% | $- | - | |
| Sep 21, 2026 | $0.06 | -94.92% | $7.18 | +1634.30% | -1729.22% |
| Sep 18, 2026 | $0.06 | -95.21% | $7.16 | +1629.47% | -1724.68% |
| Sep 17, 2026 | $0.08 | -93.79% | $7.49 | +1709.18% | -1802.97% |
| Sep 16, 2026 | $0.07 | -94.47% | $7.81 | +1786.47% | -1880.94% |
| Sep 15, 2026 | $0.04 | -96.31% | $9.00 | +2073.91% | -2170.22% |
| Sep 14, 2026 | $0.05 | -96.27% | $11.63 | +2709.18% | -2805.45% |
| Sep 11, 2026 | $0.05 | -95.79% | $8.61 | +1979.71% | -2075.50% |
| Sep 10, 2026 | $0.05 | -95.87% | $6.18 | +1392.75% | -1488.62% |
| Sep 09, 2026 | $0.05 | -96.12% | $5.98 | +1344.44% | -1440.56% |
| Sep 08, 2026 | $0.04 | -96.45% | $- | - | |
| Sep 04, 2026 | $0.07 | -93.89% | $0.24 | -41.79% | -52.10% |
| Sep 03, 2026 | $0.12 | -90.25% | $0.25 | -39.13% | -51.12% |
Page 1 of 9